Breast cancer in an 18-year-old female: A fatal case report and literature review

References

• Mintzer D, Glassburn J, Mason BA, Sataloff D. Breast cancer in the very young patient: a multidisciplinary case presentation. Oncologist. 2002;7:547–54. doi:10.1634/theoncologist.7-6-547.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100:1643–8. doi:10.1093/jnci/djn344.
   PubMedGoogle Scholar
• Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: Poor survival despite intensive treatment. PLoS ONE. 2009;4:e7695. doi:10.1371/journal.pone.0007695.
   PubMed Web of Science ®Google Scholar
• Hickey M, Peate M, Saunders CM, Friedlander M. Breast cancer in young women and its impact on reproductive function. Hum Reprod Update. 2009;15:323–39. doi:10.1093/humupd/dmn064.
   PubMed Web of Science ®Google Scholar
• Tichy JR, Lim E, Anders CK. Breast cancer in adolescents and young adults: a review with a focus on biology. J Natl Compr Canc Netw. 2013;11:1060–9. doi:10.6004/jnccn.2013.0128.
   PubMed Web of Science ®Google Scholar
• Polish National Cancer Registry website. www.onkologia.org.pl; accessed on July 04, 2017.
   Google Scholar
• Evans JP, Skrzynia C, Susswein L, Harlan M. Genetics and the young woman with breast cancer. Breast Dis. 2005-2006;23:17–29. doi:10.3233/BD-2006-23104.
   PubMedGoogle Scholar
• Levy-Lahad E, Friedman E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2007;96:11–5. doi:10.1038/sj.bjc.6603535.
   PubMed Web of Science ®Google Scholar
• Lubiński J, Górski B, Huzarski T, Byrski T, Gronwald J, Serrano-Fernández P, Domagała W, Chosia M, Uciński M, Grzybowska E, et al. BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat. 2006;99:71–6. doi:10.1007/s10549-006-9182-3.
   PubMed Web of Science ®Google Scholar
• Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Płużańska A, Bębenek M, Fischer-Maliszewska Ł, Grzybowska E, et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet. 2000;66:1963–8. doi:10.1086/302922.
   PubMed Web of Science ®Google Scholar
• Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Dębniak T, Byrski T, Kluźniak W, Wokołorczyk D, et al. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clin Genet. 2015;87:288–92. doi:10.1111/cge.12360.
   PubMed Web of Science ®Google Scholar
• Kraus C, Hoyer J, Vasileiou G, Wunderle M, Lux MP, Fasching PA, Krumbiegel M, Uebe S, Reuter M, Beckmann MW, et al. Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2. Int J Cancer. 2017;140:95–102. doi:10.1002/ijc.30428.
   PubMed Web of Science ®Google Scholar
• Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, et al. Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol. 2009;27:1250–6. doi:10.1200/JCO.2008.16.6959.
   PubMed Web of Science ®Google Scholar
• Cybulski C, Lubiński J, Wokołorczyk D, Kuźniak W, Kashyap A, Sopik V, Huzarski T, Gronwald J, Byrski T, Szwiec M, et al. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland. Clin Genet. 2015;88:366–70. doi:10.1111/cge.12524.
   PubMed Web of Science ®Google Scholar
• Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, Dębniak T, Górski B, et al. and the Polish Hereditary Breast Cancer Consortium. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol. 2015;16:638–44. doi:10.1016/S1470-2045(15)70142-7.
   PubMed Web of Science ®Google Scholar
• Cybulski C, Carrot-Zhang J, Kluźniak W, Rivera B, Kashyap A, Wokołorczyk D, Giroux S, Nadaf J, Hamel N, Zhang S, et al. Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet. 2015;47:643–6. Erratum in: Nat Genet 2016;48:473. doi:10.1038/ng.3284.
   PubMed Web of Science ®Google Scholar
• Nevanlinna H, Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene. 2006;25:5912–9. doi:10.1038/sj.onc.1209877.
   PubMed Web of Science ®Google Scholar
• Serrano-Fernández P, Dębniak T, Górski B, Bogdanova N, Dörk T, Cybulski C, Huzarski T, Byrski T, Gronwald J, Wokołorczyk D, et al. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Breast Cancer Res Treat. 2009;117:161–5. doi:10.1007/s10549-008-0249-1.
   PubMed Web of Science ®Google Scholar
• Bogdanova N, Enβen-Dubrowinskaja N, Feshchenko S, Lazjuk GI, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Dörk T. Association of two mutations in the CHEK2 gene with breast cancer. Int J Cancer. 2005;116:263–6. doi:10.1002/ijc.21022.
   PubMed Web of Science ®Google Scholar
• Cybulski C, Wokołorczyk D, Huzarski T, Byrski T, Gronwald J, Górski B, Dębniak T, Masojć B, Jakubowska A, van de Wetering T, et al. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat. 2007;102:119–22. doi:10.1007/s10549-006-9320-y.
   PubMed Web of Science ®Google Scholar
• Cybulski C, Wokołorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Masojć B, Dębniak T, Górski B, Blecharz P, et al. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol. 2011;29:3747–52. doi:10.1200/JCO.2010.34.0778.
   PubMed Web of Science ®Google Scholar
• Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, et al. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat. 2014;145:553–62. doi:10.1007/s10549-014-2971-1.
   PubMed Web of Science ®Google Scholar
• Bąk A, Janiszewska H, Junkiert-Czarnecka A, Heise M, Pilarska-Deltow M, Laskowski R, Pasińska M, Haus O. A risk of breast cancer in women – carriers of constitutional CHEK2 gene mutations, originating from the North – Central Poland. Hered Cancer Clin Pract. 2014;12:10. doi:10.1186/1897-4287-12-10.
   PubMed Web of Science ®Google Scholar
• Górski B, Narod SA, Lubiński J. A common missense variant in BRCA2 predisposes to early onset breast cancer. Breast Cancer Res. 2005;7:R1023–7. doi:10.1186/bcr1338.
   PubMed Web of Science ®Google Scholar
• Pabalan N, Francisco-Pabalan O, Sung L, Jarjanazi H, Ozcelik H. Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer. Breast Cancer Res Treat. 2010;124:531–41. doi:10.1007/s10549-010-0863-6.
   PubMed Web of Science ®Google Scholar
• Yan Y, Liang H, Light M, Li T, Deng Y, Li M, Li S, Qin X. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis. Tumour Biol. 2014;35:1907–15. doi:10.1007/s13277-013-1256-3.
   PubMedGoogle Scholar
• Huzarski T, Lener M, Domagała W, Gronwald J, Byrski T, Kurzawski G, Suchy J, Chosia M, Woyton J, Ucinski M, et al. The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat. 2005;89:91–3. doi:10.1007/s10549-004-1250-y.
   PubMed Web of Science ®Google Scholar
• Lubiński J, Huzarski T, Kurzawski G, Suchy J, Masojć B, Mierzejewski M, Lener M, Domagała W, Chosia M, Teodorczyk U, et al. The 3020insC allele of NOD2 predisposes to cancer of multiple organs. Hered Cancer Clin Practice. 2005;3:59–63. doi:10.1186/1897-4287-3-2-59.
   PubMed Web of Science ®Google Scholar
• Janiszewska H, Haus O, Lauda-Świeciak A, Bąk A, Mierzwa T, Sir J, Laskowski R. The NOD2 3020insC mutation in women with breast cancer from the Bydgoszcz Region in Poland. First results. Hered Cancer Clin Pract. 2006;4:15–9. doi:10.1186/1897-4287-4-1-15.
   PubMedGoogle Scholar
• Kurzawski G, Suchy J, Cybulski C, Matyjasik J, Dębniak T, Górski B, Huzarski T, Janicka A, Szymańska-Pasternak J, Lubiński J. DNA testing for variants conferring low or moderate increase in the risk of cancer. Hered Cancer Clin Pract. 2008;6:84–7. doi:10.1186/1897-4287-6-2-84.
   PubMed Web of Science ®Google Scholar
• Fernandopulle SM, Cher-Siang Ang P, Tan PH. Breast carcinoma in women 35 years and younger: a pathological study. Pathology. 2006;38:219–22. doi:10.1080/00313020600699268.
   PubMed Web of Science ®Google Scholar
• Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, et al. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012;131:1061–6. doi:10.1007/s10549-011-1872-9.
   PubMed Web of Science ®Google Scholar
• Keegan TH, Press DJ, Tao L, DeRouen MC, Kurian AW, Clarke CA, Gomez SL. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Breast Cancer Res. 2013;15:R95. doi:10.1186/bcr3556.
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429–34. doi:10.1158/1078-0432.CCR-06-3045.
   PubMed Web of Science ®Google Scholar
• Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26:3324–30. Erratum in: J Clin Oncol 2011;29:3721. doi:10.1200/JCO.2007.14.2471.
   PubMed Web of Science ®Google Scholar
• Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, Perou CM. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol. 2011;29:e18–20. doi:10.1200/JCO.2010.28.9199.
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48. doi:10.1056/NEJMra1001389.
   PubMed Web of Science ®Google Scholar
• Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994;12:888–94. doi:10.1200/JCO.1994.12.5.888.
   PubMed Web of Science ®Google Scholar
• Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol. 2002;13:273–9. doi:10.1093/annonc/mdf039.
   PubMed Web of Science ®Google Scholar
• Colleoni M, Anders CK. Debate: The biology of breast cancer in young women is unique. Oncologist. 2013;18:e13–5. doi:10.1634/theoncologist.2013-0118.
   PubMedGoogle Scholar
• Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL, Buzdar AU, Hortobagyi GN, Theriault RL. Female patients with breast carcinoma age 30 years and younger have a poor prognosis. The M.D. Anderson Cancer Center experience. Cancer. 2001;92:2523–8. doi:10.1002/1097-0142(20011115)92:10%3c2523::AID-CNCR1603%3e3.0.CO;2-6.
   PubMed Web of Science ®Google Scholar
• Azim HA Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res. 2012;18:1341–51. doi:10.1158/1078-0432.CCR-11-2599.
   PubMed Web of Science ®Google Scholar
• Freedman RA, Partridge AH. Emerging data and current challenges for young, old, obese, or male patients with breast cancer. Clin Cancer Res. 2017;23:2647–54. doi:10.1158/1078-0432.CCR-16-2552.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Schnabel B. DNA isolation by rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet. 1993;31:321–8. doi:10.1007/BF00553174.
   PubMed Web of Science ®Google Scholar
• Paszkowska-Szczur K, Scott RJ, Górski B, Cybulski C, Kurzawski G, Dymerska D, Gupta S, van de Wetering T, Masojć B, Kashyap A, et al. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. Mol Biol Rep. 2015;42:755–64. doi:10.1007/s11033-014-3824-z.
   PubMed Web of Science ®Google Scholar
• Dulude AM, D'Souza J, Harrison N, Ramanathan RK. Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutation. Clin Breast Cancer. 2011;11:268–9. doi:10.1016/j.clbc.2010.11.001.
   PubMed Web of Science ®Google Scholar
• Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol. 2008;26:4282–8. doi:10.1200/JCO.2008.16.6231.
   PubMed Web of Science ®Google Scholar
• Dębniak T, Scott RJ, Huzarski T, Byrski T, Masojć B, van de Wetering T, Serrano-Fernandez P, Górski B, Cybulski C, Gronwald J, et al. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat. 2006;98:209–15. doi:10.1007/s10549-005-9151-2.
   PubMed Web of Science ®Google Scholar
• Lubinski J, Korzen M, Gorski B, Cybulski C, Debniak T, Jakubowska A, Medrek K, Matyjasik J, Huzarski T, Byrski T, et al. Breast cancer susceptibility genes. J BUON. 2007;12(Suppl 1):S23–9.
   PubMedGoogle Scholar